ENLIVEN THERAPEUTICS INC

ELVNNASDAQ

🏆 #1378 by market capEarnings Nov 11US Equity

$379.35▲ $20.11 (+5.30%)

Simulated price

1h—

24h▲ 5.3%

7d▲ 534.9%

14d▲ 617.0%

30d▲ 645.6%

1y▲ 1907.1%

🏦Market Cap

$4.31B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Fair

🔭

No analyst ratings for ELVN

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.